The role of RhoA/Rho kinase pathway in endothelial dysfunction
- Lin Yao,
- ,
- Haroldo A. Toque,
- Guang Yang,
- Ruth B. Caldwell,
- R. William Caldwell
- Medical College of Georgia,
- ,
Scholary Output:
Contribution to journal
Review article
Peer-reviewOpen access
Abstract
Endothelial dysfunction is a key event in the development of vascular disease, and it precedes clinically obvious vascular pathology. Abnormal activation of the RhoA/Rho kinase (ROCK) pathway has been found to elevate vascular tone through unbalancing the production of vasodilating and vasoconstricting substances. Inhibition of the RhoA/ROCK pathway can prevent endothelial dysfunction in a variety of pathological conditions. This review, based on recent molecular, cellular, and animal studies, focuses on the current understanding of the ROCK pathway and its roles in endothelial dysfunction.
Publication Information
Output type
Scholary Output:
Contribution to journal
Review article
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 165-170 (6 pages)Journal (Volume, Issue Number)
Journal of Cardiovascular Disease Research (Volume 1, Issue 4)Publication milestones
- Published - 2010
Publication status
Published - 2010
ISSN
0975-3583Publication IDs
- Scopus: 79952937372
- PubMed: 21264179
Publication metrics
Metrics
SciVal
citations
66
SciVal
FWCI
0.92
SciVal
Author count
6
SciVal
Paper percentile
93
SciVal
Top percentile
10
Fractional count
4
Fractional count
0.67
Fractional count
2
Fractional count
0.33
Fractional count
4
Fractional count
1
PlumX, opens in new tab
Citation count
126
Captures
136
